Skip to main content
HOPA Abstracts
Treatment Persistence and Dose Modifications in US Patients With Hormone Receptor–Positive, HER2-Negative, Node-Positive, Early Breast Cancer Treated With Adjuvant Abemaciclib
Abstract #CR20
Astra Liepa, PharmD, BS
Read More
HOPA Abstracts
Operational and Financial Impact of Electronic Medical Record–Integrated Biomarker Testing Workflows on Specialty Pharmacy in Non–Small Cell Lung Cancer
Abstract #CR21
Kelsey Schildknecht, PharmD; Lauren Gilmer, PharmD
Read More
HOPA Abstracts
Oxaliplatin Desensitization—A Promising Approach for Patients With Cancer and Hypersensitivity Reactions: Real-World Experience From Vietnam
Abstract #LB01
Le Trang Nguyen
Read More
HOPA Abstracts
Infusion Pharmacist–Driven Romiplostim Dosing Protocol to Optimize Efficiency in an Outpatient Hematology and Oncology Cancer Center
Abstract #LB02
Ashley Jones, PharmD, BCOP; Hetalkumari Patel, PharmD, BCOP; Kailee Gaines, PharmD, BCOP
Read More
HOPA Abstracts
Pharmacist-Led Management of Vorasidenib in Patients With Isocitrate Dehydrogenase Mutation–Positive Gliomas
Abstract #LB03
Marie Noelle Bate Baiyee, PharmD; Mary Hilliger, PharmD; Bilge Parlakkilic, PharmD
Read More
HOPA Abstracts
Building Real-World Evidence Through the HERO Consortium: A Pharmacist-Led Multicenter Initiative
Abstract #LB04
Ila M. Saunders, PharmD, BCOP; Sarah Profitt, PharmD, BCOP
Read More
HOPA Abstracts
Hybrid Observation Model for Bispecific T-Cell Engager
Abstract #LB05
Alyssa Cendagorta, PharmD, BCOP
Read More
HOPA Abstracts
Pharmacist and Nurse Preferences for Preparing Large-Volume Subcutaneous Oncology Drugs During a Patient Capacity Crisis in the United Kingdom: A Discrete-Choice Study Comparing Manual Syringe Versus an On-Body Injector
Abstract #LB06
Haydon DuMond, PharmD
Read More
Online First
Original Research, Checkpoint Inhibitors, Adverse Events, Lung Cancer
Impact of Hyperglycemia During Immune Checkpoint Inhibitor Treatment for Advanced Non–Small Cell Lung Cancer: A Retrospective, Single-Center Study
Allison L. Thurman, PharmD; Susan Storey, PhD, RN, ACONS, FCNS; David J. Reeves, PharmD, BCOP
Read More
Online First
Original Research, Adverse Events, Drug–Drug Interaction
Management Patterns and Perceived Educational Needs Related to Cancer Therapy Cardiovascular Toxicities for Cardio-Oncology Providers
Sarah Kaspari, PharmD; Heather Moore, PharmD, BCOP, CPP; Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS, CACP; Sarah Hayes, PharmD, BCOP; Kristen Santiago, PharmD, BCOP; Israa Yaseen, BPharm, BCCP, BCPS, FACC, et al.
Read More
Page 4 of 197
Results 31 - 40 of 1963